Skip to main content
ArcticZymes Technologies logo

ArcticZymes Technologies — Investor Relations & Filings

Ticker · AZT ISIN · NO0010014632 LEI · 5967007LIEEXZXGR7K47 BR Manufacturing
Open in API
Filings indexed 968 across all filing types
Latest filing 2024-02-08 Director's Dealing
Country NO Norway
Listing BR AZT

About ArcticZymes Technologies

https://arcticzymes.com/

ArcticZymes Technologies is a life sciences company specializing in the development, manufacturing, and commercialization of novel recombinant enzymes. Leveraging over 30 years of expertise, the company discovers and engineers enzymes from cold-adapted Arctic marine organisms. These enzymes are designed to solve specific challenges in molecular applications, demonstrating high efficiency in demanding conditions such as low temperatures and high salinity. The product portfolio, including Salt Active Nucleases (SAN) and Cod Uracil-DNA Glycosylase, serves global partners in molecular diagnostics, gene therapy, vaccine production, and biomanufacturing. All products are manufactured at its ISO 13485 certified facility, ensuring high quality and performance for research and commercial use.

Recent filings

Filing Released Lang Actions
Long-Term Incentive Plan - grant of share options to primary insider
Director's Dealing Classification · 100% confidence The document is titled 'Notification and public disclosure of transactions by primary insider' and details a transaction involving a 'CFO / primary insider' named Børge Sørvoll. Specifically, it reports the 'Award of options' for 100,000 shares. This type of filing, reporting personal share transactions by company directors and executives (insider trades), directly corresponds to the definition of Director's Dealing.
2024-02-08 English
Long-Term Incentive Plan - grant of share options to primary insider
Remuneration Information Classification · 99% confidence The document explicitly details the grant of 100,000 share options to the CFO (a primary insider) under the Long-Term Incentive Plan. This action involves reporting personal share transactions by a company director/executive (insider trading/holding changes). This directly aligns with the definition of 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives. Although it involves remuneration guidelines (DEF 14A), the core action reported is the transaction itself, making DIRS the most precise fit. The document length is short (1496 chars), but it is a direct announcement of the transaction, not an announcement of a separate report.
2024-02-08 English
ArcticZymes Technologies ASA Q4 and 12M 2023 results
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Report' and covers the 4th Quarter and full-year 2023 performance for ArcticZymes Technologies. It contains detailed financial statements, operational reviews, and key financial figures, which confirms it is a comprehensive interim/quarterly report rather than just an announcement or a summary. It meets the criteria for an Interim/Quarterly Report (IR). Q4 2023
2024-02-01 English
ArcticZymes Technologies ASA Q4 and 12M 2023 results
Earnings Release Classification · 98% confidence The document provides key financial highlights (sales, EBITDA) for the fourth quarter and the full year 2023, which is characteristic of an Earnings Release (ER). It explicitly states the results for the period ending December 31, 2023. Although it mentions that the full report will be available later, the content provided here is the initial announcement of the key figures, fitting the definition of an Earnings Release (ER). It is too detailed for just a Report Publication Announcement (RPA) but lacks the comprehensive nature of a full Interim Report (IR) or Annual Report (10-K). The document length (3392 chars) supports this being a summary announcement rather than the full filing. Q4 2023
2024-02-01 English
ArcticZymes Technologies ASA Q4 and 12M 2023 results
Earnings Release Classification · 100% confidence The document explicitly reports the financial results for 'ArcticZymes Technologies ASA Q4 and 12M 2023 results'. It provides key financial highlights (sales, EBITDA, operating expenses, cash flow) for the fourth quarter and the full year 2023. This content structure is characteristic of an Earnings Release (ER), which is the initial announcement of periodical financial results, focusing on key highlights rather than the comprehensive detail found in a full Interim Report (IR) or Annual Report (10-K). The document also announces a subsequent presentation/webcast, which is common for an ER. Q4 2023
2024-02-01 English
ArcticZymes Technologies ASA Q4 2023 Presentation
Report Publication Announcement Classification · 98% confidence The document is titled 'ArcticZymes Technologies ASA Q4 2023 Presentation' and explicitly states that the company 'presents on February 1, 08:30 its interim report for the fourth quarter and 12 months of 2023'. Crucially, it ends with the statement 'Please find the presentation attached.' Given the very short length (526 chars) and the nature of announcing a presentation/report availability rather than containing the full report content, this fits the definition of a Report Publication Announcement (RPA). It is not the full Interim Report (IR) or Annual Report (10-K), but the announcement of the presentation materials.
2024-02-01 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.